Register entry
Rottendorf Pharma GmbH
- Registered sites
- 1
- Drug products
- 17
- Live patents
- 0
- Countries
- 1
- Base
- Germany
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Rottendorf Pharma GmbH | EnnigerlohGermany | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003732290 |
Catalogue
Marketed products
17Showing 17 of 17.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Acoramidis hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | EMPAGLIFLOZIN | TABLET | DRUG FOR FURTHER PROCESSING |
| - | EMPAGLIFLOZIN | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Lenacapavir sodium | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Tacrolimus | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Tacrolimus | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Tacrolimus | TABLET | DRUG FOR FURTHER PROCESSING |
| - | bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | emtricitabine and tenofovir alafenamide fumarate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | emtricitabine and tenofovir disoproxil fumarate | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | emtricitabine, rilpivirine hydrochloride and tenofovir disoproxil fumarate | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | sodium phenylbutyrate | PELLET | DRUG FOR FURTHER PROCESSING |
| - | tamsulosin hydrochloride | CAPSULE, GELATIN COATED | DRUG FOR FURTHER PROCESSING |
| - | telmisartan and hydrochlorothiazide | TABLET | DRUG FOR FURTHER PROCESSING |
| - | telmisartan and hydrochlorothiazide | TABLET | DRUG FOR FURTHER PROCESSING |
| - | telmisartan and hydrochlorothiazide | TABLET | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.